Markets:

Overview

News

Currencies

International

Treasuries

Perrigo (NY:PRGO)

13.31 -0.05 (-0.37%)

Official Closing Price Updated: 7:00 PM EST, Dec 18, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Perrigo

< Previous 1 2 3 4 5 6 Next >

Earnings Scheduled For November 7, 2023 ↗

November 07, 2023

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.

Via Benzinga

Preview: Perrigo's Earnings ↗

November 06, 2023

Via Benzinga

Cramer Says This AI Company 'Actually Lived Up To Their Hype': Stock Is Up 148% This Year ↗

October 03, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Energy Transfer LP (NYSE: ET) is "good."

Via Benzinga

Topics Artificial Intelligence

Perrigo Supports Customers through Tough Times, Supporting Shareholders through Changes ↗

September 19, 2023

Via Benzinga

With a Big Catalyst in Hand, Is Perrigo Company a Buy? ↗

July 21, 2023

Regulators just ruled that one of its products can be sold over the counter.

Via The Motley Fool

PRGO Stock Alert: Perrigo Climbs on Landmark FDA Birth Control Decision ↗

July 14, 2023

Perrigo (PRGO) stock is rising on Friday as investors react to the company's over-the-counter birth control pill getting FDA approval.

Via InvestorPlace

FDA Approves Over-the-Counter Birth Control Pill. Is the Pill Maker's Stock Set to Soar? ↗

July 14, 2023

Perrigo picked up a milestone regulatory win.

Via The Motley Fool

First Birth Control Pill For OTC Use In US Lands FDA Approval ↗

July 13, 2023

Perrigo Company plc (NYSE: PRGO) shares are trading higher after the FDA approved the company's Opill, a progestin-only daily oral contraceptive for over-the-counter

Via Benzinga

Perrigo Q1 Earnings Beat Estimates On Strategic Pricing, CEO Plans Retirement ↗

May 09, 2023

Via Benzinga

FDA Sets New Adcomm Date To Review Perrigo's Oral Contraceptive Pill For OTC Use ↗

March 28, 2023

Via Benzinga

Earnings Outlook For Perrigo Co ↗

February 24, 2023

Via Benzinga

Perrigo Picks Former Bayer Executive As New CEO ↗

June 08, 2023

Perrigo Co PLC (NYSE: PRGO) disclosed the appointment of Patrick Lockwood-Taylor as its new President, CEO and member of the Board of Directors,

Via Benzinga

$4.5M Bet On This Energy Stock? Check Out These 3 Stocks Insiders Are Buying ↗

May 26, 2023

Although US stocks closed mostly higher on Thursday, there were a few notable insider trades.

Via Benzinga

FDA Raises Concerns Regarding Perrigo's OTC Birth Control Pill, Casts Doubts Over Real-World Use ↗

May 08, 2023

The FDA's Nonprescription Drugs Advisory Committee (NDAC) and the Obstetrics, Reproductive, and Urologic Drugs Advisory Committee (ORUDAC) will be meeting this week to review Perrigo Company...

Via Benzinga

Republicans Seek Documents, Schedule Hearing Related To FDA's Response To Baby-Formula Shortage ↗

March 21, 2023

House Republicans are reportedly speeding up their scrutiny of the FDA and the White House's handling of the baby formula shortage last year.

Via Benzinga

Insiders Selling Perrigo And 3 Other Stocks ↗

March 10, 2023

The Nasdaq Composite dropped by around 2% on Thursday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023 ↗

March 07, 2023

Via Benzinga

Earnings Scheduled For February 27, 2023 ↗

February 27, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million.

Via Benzinga

Why Perrigo Stock Tanked on Tuesday ↗

November 08, 2022

A double miss and a guidance cut badly affected investor sentiment.

Via The Motley Fool

7 Perfect Presents to Gift Your 2023 Stock Portfolio ↗

December 21, 2022

As we leave 2022 behind, these hot stocks to buy have significant potential and serious catalysts as we move into New Year 2023.

Via InvestorPlace

SWEDEN’S SKINCARE SENSATION ACO EXTENDS PRESENCE INTO US TIMED TO THE HOLIDAY SEASON

December 16, 2022

Stolkholm’s Best Kept Skincare Secret Is The Perfect Gift For Giving

From ACO

Via GlobeNewswire

Perrigo, Tripadvisor, Lyft, And Some Other Big Stocks Moving Lower On Tuesday ↗

November 08, 2022

U.S. stocks traded higher, with the Dow Jones gaining more than 400 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

FDA Postpones Review Meeting For First OTC Contraceptive Option From Perrigo ↗

October 26, 2022

Via Benzinga

Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday ↗

November 09, 2022

Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday.

Via Benzinga

Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday's Mid-Day Session ↗

November 08, 2022

Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast...

Via Benzinga

Perrigo Shares Fall As Investors React To Lowered FY22 Profit Guidance ↗

November 08, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022 ↗

September 14, 2022

Upgrades For Iris Energy Ltd (NASDAQ:IREN), Compass Point upgraded the previous rating of Neutral to Buy. The current stock performance of Iris Energy shows a 52-week-high of $17.97 and a 52-week-low...

Via Benzinga

FDA Schedules AdComm Review For First Over The Counter Birth Control Pill ↗

September 13, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2022 ↗

September 06, 2022

Upgrades

Via Benzinga

Is Sanofi A Buy, Despite Recent Stumbles?

August 19, 2022

Pharmaceuticals are subject to whiplash trade. That's evident with sharp moves lower in Sanofi, GSK and Teva on news about clinical trials and legal actions.

Via MarketBeat

Topics Intellectual Property

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Perrigo (NY:PRGO)

All News about Perrigo

Starting at $3.75/week.

Subscribe Today